Target intelligence / Profile preview

Neuronal-glial microenvironment

Molecular classification
Other
01

Overview

The neuronal-glial microenvironment is the integrated system of neurons and supporting glial cells—including astrocytes, microglia, and oligodendrocytes—within the central nervous system (Verkhratsky & Nedergaard, 2018, Physiological Reviews). This microenvironment is fundamental for maintaining physiological homeostasis, providing metabolic substrates like lactate to neurons, and regulating the extracellular ionic environment and neurotransmitter levels (Allen & Lyons, 2018, Science). It also encompasses the 'tripartite synapse,' where astrocytes actively participate in synaptic signaling and plasticity (Perea et al., 2009, Trends in Neurosciences). In many neurological disorders, this environment becomes 'reactive' or dysfunctional, contributing to neuroinflammation and neuronal death (Glass et al., 2010, Cell). While the microenvironment itself is a systemic concept rather than a single molecular target, it serves as a critical therapeutic context for drugs like Fingolimod or Memantine, which are designed to modulate neuro-glial crosstalk and restore healthy brain function (Brinkmann et al., 2010, Nature Reviews Drug Discovery). Understanding the spatial and temporal dynamics of this niche is essential for developing precision therapies for neurodegenerative and neuroinflammatory conditions.

Other names
Neuro-glial unitTripartite synapseCNS microenvironmentGlial-neuronal interface
02

Mechanism of action

Modulation of glial activation states, regulation of extracellular glutamate and ion concentrations, and inhibition of pro-inflammatory cytokine release within the neuro-glial unit.

03

Biological functions

Synaptic transmissionMetabolic supportHomeostasisNeuroinflammationBlood-brain barrier maintenanceMyelinationNeuroprotection
04

Disease associations

Neurodegenerative diseaseMultiple sclerosisEpilepsyChronic painStrokeBrain cancerNeuroinflammation
05

Safety considerations

Disruption of CNS homeostasisPotential for neurotoxicitySystemic immunosuppressionBlood-brain barrier permeability changes
06

Interacting drugs

Fingolimod

4 more in the full profile.

07

Biomarkers

Glial fibrillary acidic protein (GFAP)Ionized calcium-binding adapter molecule 1 (Iba1)Neurofilament light chain (NfL)S100BYKL-40

Beyond the preview

Go deeper on Neuronal-glial microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal-glial microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call